Stock & Company Details
Gyre Therapeutics Inc $GYRE
Price:
N/A
N/A
115M
$495M
52 Week High:
N/A
10 Day Average Volume:
N/A
-24.46
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GYRE technical indicators
Latest Gyre Therapeutics Inc (GYRE) indicator readings as of 2026-11-19.
GYRE's 14-day RSI is 40.5, in neutral territory. ADX reads 29.1, indicating a trending market. MACD (12, 26, 9) is -0.52, below the zero line.
Overview
catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.
Finance Bot
Ask your questions
Start by typing a question below.